Jamie Orengo

2.0k total citations · 1 hit paper
38 papers, 902 citations indexed

About

Jamie Orengo is a scholar working on Immunology, Physiology and Immunology and Allergy. According to data from OpenAlex, Jamie Orengo has authored 38 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Physiology and 12 papers in Immunology and Allergy. Recurrent topics in Jamie Orengo's work include Asthma and respiratory diseases (16 papers), IL-33, ST2, and ILC Pathways (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Jamie Orengo is often cited by papers focused on Asthma and respiratory diseases (16 papers), IL-33, ST2, and ILC Pathways (12 papers) and Allergic Rhinitis and Sensitization (10 papers). Jamie Orengo collaborates with scholars based in United States, France and Sweden. Jamie Orengo's co-authors include Matthew A. Sleeman, Andrew Murphy, George D. Yancopoulos, Seblewongel Asrat, Wei Keat Lim, Neil Stahl, George Scott, Dylan Birchard, Jeanne Allinne and Ana Rodrı́guez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jamie Orengo

36 papers receiving 885 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

2019 330 citations Audrey Le Floc’h, Jeanne Allinne et al. Allergy profile →

Peers

Countries citing papers authored by Jamie Orengo

Since Specialization

Citations

This map shows the geographic impact of Jamie Orengo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Orengo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Orengo more than expected).

Fields of papers citing papers by Jamie Orengo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie Orengo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Orengo. The network helps show where Jamie Orengo may publish in the future.

Co-authorship network of co-authors of Jamie Orengo

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie Orengo. A scholar is included among the top collaborators of Jamie Orengo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie Orengo. Jamie Orengo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy 2024 ·Allergy ·Matthew F. Wipperman, Kaitlyn Gayvert, Amanda Atanasio, Claire Q. Wang, Jonathan Corren, (unknown), Ian Setliff, (unknown), Elizabeth Laws, (unknown), Sivan Harel, Jennifer Maloney, Gary Herman, Jamie Orengo, Wei Keat Lim, Sara Hamon, Jennifer D. Hamilton, Meagan P. O’Brien	12
2	Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review) 2024 ·Advances in Therapy ·Victoria P. Werth, (unknown), P. Joly, (unknown), Jamie Orengo, Marius Ardeleanu, (unknown)	4
3	IL-4 And IL-13 Have Distinct And Overlapping Effects On Key Cell Types Involved In The Pathobiology Of Atopic Dermatitis 2023 ·Journal of Allergy and Clinical Immunology ·Subhashini Srivatsan, (unknown), Kirsten Nagashima, (unknown), (unknown), Wei Keat Lim, Andrew Murphy, Matthew A. Sleeman, Jamie Orengo	2
4	IL-33 Initiates and Amplifies Both Type 1 and Type 2 Inflammation 2023 ·Journal of Allergy and Clinical Immunology ·Seblewongel Asrat, Kirsten Nagashima, G. Richard Scott, (unknown), Audrey Le Floc’h, Subhashini Srivatsan, Jeanne Allinne, Andrew Murphy, Matthew A. Sleeman, Jamie Orengo	1
5	Interleukin-33 (IL-33) Drives Type 1 and Type 2 Inflammation and Instructs Airway Remodeling 2023 ·Subhashini Srivatsan, Seblewongel Asrat, Kirsten Nagashima, George Scott, Wei Keat Lim, Dylan Birchard, Li‐Hong Ben, Audrey Le Floc’h, Jeanne Allinne, Andrew Murphy, Mark W. Sleeman, Jamie Orengo	0
6	TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells 2023 ·Cell Reports Methods ·Seblewongel Asrat, Joseph C. Devlin, Andrea Vecchione, (unknown), Ian Setliff, (unknown), André Limnander, Ashique Rafique, Christina Adler, Stephen B. Porter, Andrew Murphy, Gurinder S. Atwal, Matthew A. Sleeman, Wei Keat Lim, Jamie Orengo	7
7	IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline 2022 ·Cytokine ·George Scott, Seblewongel Asrat, Jeanne Allinne, Wei Keat Lim, Kirsten Nagashima, Dylan Birchard, Subhashini Srivatsan, Dharani K. Ajithdoss, A. Oyejide, Li‐Hong Ben, Johnathon R. Walls, Audrey Le Floc’h, George D. Yancopoulos, Andrew Murphy, Matthew A. Sleeman, Jamie Orengo	54
8	REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit 2022 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Claire Q. Wang, Jamie Orengo, (unknown), Divya Ramesh, Jessica J. Jalbert, Mohamed Kamal, Hisham Abdallah, Robert Dingman, Lorah Perlee, David M. Weinreich, Gary Herman, George D. Yancopoulos, Meagan P. O’Brien	28
9	Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities 2022 ·SHILAP Revista de lepidopterología ·Amanda Atanasio, Jamie Orengo, Matthew A. Sleeman, Neil Stahl	11
10	Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial 2021 ·American Journal of Respiratory and Critical Care Medicine ·Mohamed H. Shamji, (unknown), Janice A. Layhadi, (unknown), Angeliki Karamani, Lubna Kouser, Hanisah Sharif, (unknown), (unknown), Rebecca Parkin, Stephen R. Durham, Ana Kostić, Jamie Orengo, (unknown), Mohamed Kamal, Neil Stahl, George D. Yancopoulos, Claire Q. Wang, Allen Radin	55
11	Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory 2020 ·Science Immunology ·Seblewongel Asrat, (unknown), Xia Liu, Li‐Hong Ben, (unknown), Andrew Murphy, Matthew A. Sleeman, André Limnander, Jamie Orengo	60
12	Targeting birch allergy with monoclonal IgG antibodies that bind allergen and prevent IgE effector cell activation 2020 ·Journal of Allergy and Clinical Immunology ·Amanda Atanasio, Matthew C. Franklin, Li‐Hong Ben, Ashok Badithe, (unknown), Vishal Kamat, Annabel Romero Hernandez, William C. Olson, Andrew Murphy, Matthew A. Sleeman, Jamie Orengo	1
13	Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials 2020 ·Dermatitis ·Jonathan I. Silverberg, Eric L. Simpson, Emma Guttman‐Yassky, Michael J. Cork, Marjolein de Bruin‐Weller, Gil Yosipovitch, Laurent Eckert, Zhen Chen, Marius Ardeleanu, Brad Shumel, Thomas Hultsch, Ana B. Rossi, Jennifer D. Hamilton, Jamie Orengo, Marcella Ruddy, Neil M.H. Graham, Gianluca Pirozzi, Abhijit Gadkari	8
14	IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation 2019 ·Journal of Allergy and Clinical Immunology ·Jeanne Allinne, George Scott, Wei Keat Lim, Dylan Birchard, Jonas S. Erjefält, Caroline Sandén, Li-Hong Ben, Amit Agrawal, (unknown), Jee Hae Kim, Vishal Kamat, Wen Fury, Tammy Huang, Neil Stahl, George D. Yancopoulos, Andrew Murphy, Matthew A. Sleeman, Jamie Orengo	87
15	Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model 2018 ·Jamie Orengo, Jeanne Allinne, Audrey Le Floc’h, Terra Potocky, Jeeho Kim, Dylan Birchard, George Scott, Yu Bai, Ashique Rafique, Tammy Huang, Joel Martin, Matthew A. Sleeman, Andrew Murphy	4
16	A Surprising Role for Uric Acid: The Inflammatory Malaria Response 2014 ·Current Rheumatology Reports ·Julio Gallego‐Delgado, Maureen Ty, Jamie Orengo, (unknown), Ana Rodrı́guez	36
17	Uric Acid Is a Mediator of the Plasmodium falciparum-Induced Inflammatory Response 2009 ·PLoS ONE ·Jamie Orengo, Aleksandra Leliwa‐Sytek, James Evans, Barbara Evans, (unknown), (unknown), Karen P. Day, Ana Rodrı́guez	40
18	A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells 2008 ·Malaria Journal ·Jamie Orengo, K. Wong, Carlos Ocaña‐Morgner, Ana Rodrı́guez	14
19	Plasmodium-Induced Inflammation by Uric Acid 2008 ·PLoS Pathogens ·Jamie Orengo, James Evans, Esther Bettiol, Aleksandra Leliwa‐Sytek, Karen P. Day, Ana Rodrı́guez	40
20	Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL-6 2007 ·Cellular Microbiology ·Daniel Carapau, (unknown), (unknown), Jamie Orengo, Maria M. Mota, Ana Rodrı́guez	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact